Navigation Links
Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue Using Myriad RBM’s Multiplex ApoptosisMAP™, a New Biomarker Webinar by Xtalks
Date:11/19/2013

(PRWEB) November 19, 2013

Regulators of apoptotic cell death are potentially valuable targets for oncology and autoimmune disease. Several promising mechanism-based compounds that directly target the molecular components of apoptosis pathways are in clinical development. It is well known that inhibition of apoptosis occurs in most cancers and can occur by a variety of methods such up regulation of anti-apoptotic factors. Until now, profiling the key components of apoptosis has been limited by the laborious and semi-quantitative method of IP-western blot which is not amenable to multiplexing and is ill suited for clinical studies from limited sample amounts.

The ApoptosisMAP is a fully validated quantitative multiplex immunoassay that can quantify apoptotic biomarkers in clinical trials. It can support the pharmacodynamic action of investigational agents with companion diagnostic implications for identifying patients most likely to respond to a particular apoptosis inducer or other chemotherapeutic regimes. Join Dominic Eisinger, PhD, Director of Strategic Development, from Myriad RBM for this discussion on quantitative profiling using Myriad RBM’s Multi-Analyte Profile (MAP) platform.

For more information about this online seminar or to visit this webinar’s homepage, go to http://xtalks.com/Multiplex-ApoptosisMAP-quantitative-profiling.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com

Contact:
Michelle Tran, Marketing Manager
+1 (416) 977-6555 ext 224
mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325882.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Neogen Launches Fully Quantitative Lateral Flow Test for DON
2. USDA/GIPSA Approves Charm Sciences’ ROSA® FAST Aflatoxin Quantitative Test
3. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
4. Rigaku Publishes New Application Note for Quantitative Analysis of Stainless Steel
5. Rigku Publishes New Method for Quantitative Analysis of Cast Iron Using the ZSX Primus III+
6. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer
7. Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks
8. Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
11. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... , ... May 20, 2017 , ... ... helps avoid the lengthy trial and error process by finding the right antidepressant ... can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. Ralph Mobbs of ... Prince Of Wales Private Hospital. The procedure was performed on a 46-year-old male ... conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic disc is a ...
(Date:5/18/2017)... ... 2017 , ... NDA Partners Chairman Carl Peck, MD , announced today ... and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm ... he was former Chief Operating Officer at Anaborex, Senior VP and General Manager of ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, is honored that ... Traceability for Medical Devices conference in Brussels, Belgium. , Crowley played a crucial ...
Breaking Biology Technology:
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):